Introduction
For over a hundred years, radiation therapy has been a crucial method in treating cancer. It functions by harming the DNA of cancer cells, preventing them from proliferating (or multiplying) and metastasising (or spreading). The prevalent type, referred to as conventional radiation therapy, employs high-energy X-rays, commonly called photons. With the passage of time, this approach has become safer and more accurate due to computer-assisted methods.
In recent times, though, a novel form of treatment, proton therapy, has attracted interest. Hospitals advocate it as a more focused approach to treating cancer while minimising damage to healthy tissues. It seems encouraging, but in what ways is it truly distinct from conventional radiation? Is the expense and complexity justified? This article discusses both approaches in simple terms, evaluates their advantages and disadvantages, and examines what the studies truly indicate.
How does traditional radiation therapy work?
Traditional radiation therapy, or photon therapy, uses high-energy beams generated by a machine called a linear accelerator. These beams are aimed at the tumour from outside the body. Because X-rays travel through tissues, they release energy not only in the tumour but also along their path, both before and after hitting the target. That extra exposure can damage healthy cells and cause side effects.1
To reduce this problem, modern approaches such as intensity-modulated radiation therapy and volumetric modulated arc therapy (VMAT) shape and move the radiation beam around the tumour. Computers control the dose and angle to deliver more energy to the tumour and less to nearby healthy tissue. In simple terms, photon therapy resembles using a flashlight on the body: it strikes the intended spot, but some light also disperses to unintended regions. It continues to be a very efficient and readily accessible therapy, yet its energy cannot be entirely restricted to the tumour.1
How does proton therapy work?
Proton therapy employs the same fundamental principle, administering radiation to eliminate cancer cells, but substitutes X-rays for protons, the positively charged particles present in atoms. These protons speed up to extremely high velocities within a device known as a cyclotron or synchrotron, and are subsequently aimed accurately at the tumour.
What distinguishes proton therapy is the Bragg peak, a position in the proton’s trajectory where it discharges the majority of its energy. Following that peak, the radiation dosage decreases rapidly. By varying the energy of the protons, physicians can precisely manage the depth of the beam, guaranteeing that the maximum dose is administered within the tumour and not outside it.2,3
Contemporary devices employ a method called pencil beam scanning or intensity-modulated proton therapy, enabling physicians to "layer" the dose within the tumour incrementally. This provides a degree of accuracy that is hard to attain with X-rays. In simple terms, while photon therapy resembles tossing a handful of pebbles throughout the body, proton therapy is comparable to throwing a precise dart that halts exactly at the intended location.4
Precision and protection of healthy tissue
The primary difference between proton and photon therapy lies in their ability to safeguard healthy tissues. As protons can be stopped at an exact depth, doctors can protect organs near the tumour. This is especially advantageous for targeting cancers located in delicate areas such as the brain, eyes, spinal cord, or heart.5
Studies show that proton therapy significantly reduces radiation exposure to nearby organs while preserving the dose delivered to the tumour. This advantage becomes increasingly vital in the treatment of paediatric cancer. As children's tissues and bones continue to develop, limiting unnecessary radiation helps prevent developmental problems and lowers the risk of future secondary cancers.5
In head and neck cancers, for example, protons can minimise radiation exposure to the salivary glands and muscles used for swallowing, leading to fewer long-term issues with dry mouth and eating challenges.6 For patients, this can lead to a considerable improvement in comfort and recovery. In straightforward language, protons allow physicians to aim the treatment more accurately, striking the cancer while protecting vital regions.
Effectiveness and real-world results
It’s one thing to talk about physics, but what about real outcomes? Research so far suggests that proton therapy provides similar or slightly improved cancer control compared with traditional radiation, with the added benefit of fewer side effects.
A large meta-analysis on patients with oesophageal cancer found that those treated with proton therapy had comparable survival rates but experienced fewer heart and lung complications than those treated with photon therapy.2 Another study showed that protons could deliver the same tumour-killing dose while exposing less healthy tissue to radiation.1
These benefits are most noticeable in cancers close to vital structures, like brain tumours, eye tumours, or tumours in children.5 For more common cancers, such as prostate or breast cancer, traditional photon therapy remains standard because it is more widely available and considerably cheaper. In short, proton therapy is not “stronger,” but it tends to be gentler on the body.
Side effects and quality of life
All radiation therapy can cause side effects because some healthy cells are exposed along the way. Typical issues include fatigue, skin irritation, and inflammation of nearby organs.
However, proton therapy often results in milder side effects. Because the radiation stops inside the tumour, there’s less “exit dose,” which means less damage to normal tissues. Patients receiving proton therapy have been shown to experience fewer severe symptoms, such as difficulty swallowing or inflammation in the lungs.1,2,5
Over time, this can improve the overall quality of life. There is also evidence suggesting proton therapy may reduce the risk of secondary cancers, which can appear years later due to radiation exposure.5 To put it simply, both treatments work, but proton therapy tends to make the recovery process easier and more comfortable for many patients.
Cost and availability
Building and operating a proton therapy centre is extremely expensive. These facilities require huge accelerators, thick shielding, and specialised staff. A single centre can cost hundreds of millions of dollars to construct.5,7 The treatment itself can also be two to three times more expensive than standard radiation.
As a result, a restricted number of proton facilities are available globally, with the majority situated in prominent hospitals or research organisations. Numerous patients must journey great distances to access them, and insurance coverage differs based on the cancer type and the healthcare system.
To put it differently, proton therapy remains a high-end choice, effective, yet not readily available. Conversely, conventional photon therapy is widely accessible and continues to be highly effective for the majority of cancers. In simple terms, proton therapy is continually developing. Over time, it is expected to become increasingly prevalent, cheaper, and even more accurate.
The future of proton therapy
The area of proton therapy is evolving rapidly. Recent technologies are enhancing precision and flexibility. One encouraging advancement is adaptive proton therapy, allowing physicians to modify the treatment plan mid-course as the tumour alters in size or shape.6
A significant advancement is the implementation of real-time imaging throughout the treatment process. This enables clinicians to precisely observe the radiation's path and make immediate minor adjustments.6 Scientists are investigating ways to integrate protons with other cancer therapies, like chemotherapy and immunotherapy, to enhance outcomes even more.5
With the completion of additional studies, physicians will be able to determine which patients gain the greatest advantages from proton therapy. This understanding ought to lead to more individualised and cost-effective treatment choices going forward.
In simple terms, proton therapy continues to develop. Over time, it’s expected to become increasingly prevalent, less expensive, and even more accurate.
FAQs
Is proton therapy always better than regular radiation?
Not always. Proton therapy is especially useful when the tumour is close to important organs or in children, but for many cancers, traditional radiation works just as well.
Why is proton therapy so expensive?
The machines are large and complex, and the facilities need heavy shielding and advanced equipment. This makes them costly to build and operate.
Does proton therapy improve survival rates?
In most cancers, survival rates are similar to photon therapy, but proton therapy often causes fewer side effects and long-term complications.
Which cancers benefit most?
Cancers near sensitive organs, such as the brain, eye, spinal cord, and some head and neck tumours, see the biggest advantage. It is also widely used in the treatment of paediatric cancers.
Are proton therapy centres common?
Not yet. Most are located in large research or teaching hospitals, though more are being built each year.
Does proton therapy really reduce side effects?
Yes. Because it spares more normal tissue, patients often experience fewer problems, like fatigue, pain, or swallowing difficulties.
Will it become cheaper and more widely available?
Experts believe so. As more centres open and technology improves, costs should gradually decrease, making proton therapy more accessible.
Summary
Proton therapy is one of the most thrilling advancements in radiation oncology. Its capacity to target radiation exactly where required enables effective cancer management while reducing damage to healthy tissues. This accuracy may result in reduced side effects, quicker recovery, and improved long-term quality of life.
Nonetheless, conventional photon therapy continues to serve as the cornerstone of radiation therapy globally. It is efficient, thoroughly researched, and accessible in the majority of hospitals. Proton therapy serves not as a substitute but as an enhancement of radiation's capabilities. For certain patients, particularly children and individuals with tumours close to vital organs, it provides a significant benefit.
With advancements in technology and decreasing costs, proton therapy is anticipated to become increasingly available. Until that time, both treatments will remain crucial in cancer treatment, each suitable for various requirements.
References
- Hirano Y, Onozawa M, Hojo H, Motegi A, Zenda S, Hotta K, et al. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma. Radiat Oncol [Internet]. 2018 [cited 2025 Dec 13]; 13(1):23. Available from: https://doi.org/10.1186/s13014-018-0966-5.
- Zhou P, Du Y, Zhang Y, Zhu M, Li T, Tian W, et al. Efficacy and Safety in Proton Therapy and Photon Therapy for Patients With Esophageal Cancer: A Meta-Analysis. JAMA Netw Open [Internet]. 2023 [cited 2025 Dec 13]; 6(8):e2328136. Available from: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2808359.
- Lin R, Shan J, Yuan T, Qian C. Dosimetric comparison of intensity-modulated proton radiotherapy versus intensity-modulated photon-based radiotherapy for breast cancer. Vis Cancer Med [Internet]. 2021 [cited 2025 Dec 13]; 2:5. Available from: https://vcm.edpsciences.org/10.1051/vcm/2021002.
- Yuan T, Zhan Z, Qian C. New frontiers in proton therapy: applications in cancers. Cancer Communications [Internet]. 2019 [cited 2025 Dec 13]; 39(1):1–7. Available from: https://onlinelibrary.wiley.com/doi/10.1186/s40880-019-0407-3.
- Kiafi P, Chalkia M, Kouri MA, Patatoukas G, Kollaros N, Kougioumtzopoulou A, et al. Photon vs . proton radiation therapy in head and neck cancer: a review of dosimetric advantages and patient quality of life. J Cancer Metastasis Treat [Internet]. 2024 [cited 2025 Dec 13]. Available from: https://www.oaepublish.com/articles/2394-4722.2024.79.
- Argota-Perez R, Sharma MB, Elstrøm UV, Møller DS, Grau C, Jensen K, et al. Dose and robustness comparison of nominal, daily and accumulated doses for photon and proton treatment of sinonasal cancer. Radiotherapy and Oncology [Internet]. 2022 [cited 2025 Dec 13]; 173:102–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0167814022041445.
- Choi J-H, Lee JM, Kim MS, Lee Y, Suh Y-G, Lee SU, et al. A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute. Cancers [Internet]. 2022 [cited 2025 Dec 13]; 14(8):2033. Available from: https://www.mdpi.com/2072-6694/14/8/2033.
- Lideståhl A, Fredén E, Siegbahn A, Johansson G, Lind PA. Dosimetric Comparison of Conventional Radiotherapy, Volumetric Modulated Arc Therapy, and Proton Beam Therapy for Palliation of Thoracic Spine Metastases Secondary to Breast or Prostate Cancer. Cancers [Internet]. 2023 [cited 2025 Dec 13]; 15(24):5736. Available from: https://www.mdpi.com/2072-6694/15/24/5736.

